Perimeter Solutions, SA: financial analysis
Ratios worked out from 8 fiscal years of Perimeter Solutions, SA's statements, compared with 94 companies in Chemicals.
Perimeter Solutions, SA scorecard#
Passes 8 of the 23 checks that could be worked out: strongest in financial health (3 of 4), weakest in profitability (0 of 5). Fiscal year 2025; market cap of Oct 23, 2026.
Valuation1 of 6
- ✗P/E below its peers' median80.1×P/E 80.1× against Chemicals's median of 23.1×.
- ✗Price to book below its peers' median3.9×Price to book 3.9× against Chemicals's median of 2.1×.
- ✗Price to sales below its peers' median5.3×Price to sales 5.3× against Chemicals's median of 1.8×.
- ✗Free cash flow yield above 5%4.7%Free cash flow is 4.7% of the market value.
- ✗Earnings yield above the 10-year Treasury yield1.2%Earnings yield 1.2% against the 10-year Treasury's 4.92% on 2026-11-20.
- ✓The price assumes slower growth than the last three years'16.5%The price assumes 16.5% a year for ten years; revenue grew 21.9% a year over the last three.
Growth3 of 5
- ✓Revenue grew in the newest year16.4%Revenue up 16.4% in fiscal 2025.
- ✓Revenue up more than 5% a year over three years21.9%21.9% a year over the three years to fiscal 2025.
- ✓Faster growth over three years than its peers' median21.9%21.9% a year against Chemicals's median of -2.4% (60 companies).
- ✗Earnings per share grew in the newest year-1.37 vs -0.04Diluted EPS -1.37 in fiscal 2025 against -0.04 the year before (report's currency).
- ✗Net income higher than five years earlier-$206 M-$206 M in fiscal 2025 against $24 M in 2020.
- –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
Profitability0 of 5
- ✗Profitable in the newest year-$206 MNet income -$206 M in fiscal 2025.
- ✗Profitable in each of the last five years2 of 5Profitable in 2 of the five years to fiscal 2025.
- ✗Operating margin above its peers' median-30.8%-30.8% against Chemicals's median of 4.7% (73 companies).
- ✗Return on equity above 15%-18.0%-18.0% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- ✗Operating margin wider than three years earlier-30.8%-30.8% in fiscal 2025 against 36.1% in 2022.
Financial health3 of 4
- ✓Short-term assets cover short-term liabilities3.2×Current ratio 3.22 at the end of fiscal 2025.
- ✓Debt below equity0.6×Debt to equity 0.59 at the end of fiscal 2025.
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2025.
- ✗Altman Z-score outside the distress zone1.51Z-score 1.51 (distress zone) for fiscal 2025.
Shareholder returns1 of 3
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year3.2%Diluted shares up 3.2% in fiscal 2025.
- ✗Dividends and buybacks above 3% of the market value0.9%Dividends and buybacks were 0.9% of the market value.
- ✓Free cash flow covers dividends and buybacks$209 MFree cash flow $209 M against $40 M paid out in fiscal 2025.
Worked out from the statements as filed (sec), the medians of Chemicals, the 10-year Treasury yield of Nov 20, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
What the 2025 statements show#
Each line is an observation with its numbers, not a judgement of the company.
Worth a look
- Net loss of $206 million.
- Goodwill and intangibles ($2.0 billion) exceed shareholders' equity ($1.1 billion).
Piotroski F-score
Nine yes/no tests of whether the company's finances improved in the year. One point each.
- Made a profitno
- Operations brought in cashyes
- Return on assets roseno
- Cash from operations exceeds profityes
- Long-term debt fell against assetsyes
- Current ratio roseno
- No new shares issuedno
- Gross margin roseyes
- Asset turnover roseyes
Altman Z-score
A 1968 formula that weighs five balance-sheet ratios. It was built on listed manufacturers and says less about other kinds of company.
| Part | Ratio | Weight | Points |
|---|---|---|---|
| Working capital to assets | 0.15 | × 1.2 | 0.18 |
| Retained earnings to assets | -0.30 | × 1.4 | -0.42 |
| Operating income to assets | -0.08 | × 3.3 | -0.25 |
| Market value to liabilities | 2.93 | × 0.6 | 1.76 |
| Revenue to assets | 0.25 | × 1 | 0.25 |
Profitability#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 57.5% | 56.5% | 39.8% | 35.7% | — | 29.8% | 99% | |
| Operating margin | -30.8% | -0.7% | 29.3% | 36.1% | — | 4.7% | 11% | |
| Net margin | -31.6% | -1.1% | 21.0% | 25.5% | — | 2.2% | 6% | |
| Return on equity | -18.0% | -0.5% | 5.9% | 8.3% | -96.4% | 2.1% | 17% | |
| Return on assets | -8.1% | -0.3% | 2.8% | 3.6% | -35.6% | 0.9% | 15% | |
| Return on invested capital | — | — | — | 7.7% | — | 8.9% | — |
Growth#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | 16.4% | 74.2% | -10.7% | — | — | 0.4% | 91% | |
| Revenue growth, 3 years a year | 21.9% | — | — | — | — | -2.4% | 93% | |
| Net income growth | — | — | -26.5% | — | — | -4.2% | — | |
| Earnings per share growth | — | — | -21.2% | — | — | -3.4% | — |
Financial strength#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Debt to equity | 0.59× | 0.58× | 0.58× | 0.58× | 0.61× | 0.64× | 57% | |
| Net debt | $343 M | $469 M | $619 M | $539 M | $439 M | $889 M | 72% | |
| Net debt to EBITDA | — | 7.58× | 3.89× | 2.75× | — | 3.03× | — | |
| Interest cover | — | — | 2.28× | 3.05× | — | 1.48× | — | |
| Current ratio | 3.22× | 6.31× | 4.56× | 4.16× | 3.70× | 2.22× | 83% | |
| Equity share of assets | 42.7% | 47.9% | 49.8% | 46.4% | 42.0% | 48.9% | 35% |
Cash#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Free cash flow | $209 M | $173 M | $-9 M | $-49 M | — | $65 M | 68% | |
| Free cash flow margin | 32.0% | 30.8% | -2.9% | -13.5% | — | 3.7% | 99% | |
| Cash conversion | — | — | 0.3% | -43.8% | — | 177.0% | — | |
| Capital spending share of revenue | 4.5% | 2.8% | 2.9% | 2.4% | — | 4.9% | — |
Efficiency#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Asset turnover | 0.26× | 0.24× | 0.13× | 0.14× | — | 0.69× | 8% |
How each figure is worked out#
- Gross margin
- Gross profit as a share of revenue.
- Operating margin
- Operating income as a share of revenue.
- Net margin
- Net income as a share of revenue.
- Return on equity
- Net income as a share of shareholders' equity (the average of the start and the end of the year). Not given when equity is negative.
- Return on assets
- Net income as a share of total assets (average of the year).
- Return on invested capital
- Operating income after tax, as a share of debt plus equity less cash (average of the year). The tax rate is the year's own: income tax over pre-tax income.
- Revenue growth
- Revenue against the year before.
- Revenue growth, 3 years a year
- The yearly rate that takes revenue of three years earlier to this year's.
- Net income growth
- Net income against the year before. Only when both years were profitable.
- Earnings per share growth
- Diluted earnings per share against the year before. Only when both were positive.
- Debt to equity
- Total debt divided by shareholders' equity. Not given when equity is negative.
- Net debt
- Total debt less cash. Negative means more cash than debt.
- Net debt to EBITDA
- Debt less cash, divided by operating income plus depreciation and amortization: roughly the years of operating earnings needed to repay it.
- Interest cover
- Operating income divided by the interest paid on debt.
- Current ratio
- Assets due within a year divided by liabilities due within a year.
- Equity share of assets
- Shareholders' equity as a share of total assets.
- Free cash flow
- Cash from operations less capital spending.
- Free cash flow margin
- Free cash flow as a share of revenue.
- Cash conversion
- Cash from operations as a share of net income. Only when the year was profitable.
- Capital spending share of revenue
- Capital spending as a share of revenue.
- Buyback yield
- Shares bought back in the fiscal year as a share of today's market value.
- Shareholder yield
- Dividends plus buybacks as a share of today's market value.
- Change in share count
- Diluted shares against the year before. Negative: fewer shares.
- Asset turnover
- Revenue divided by total assets (average of the year).